Review Article LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly

Hugues de Boussac,A. Pommier,J. Dufour,A. Trousson,D. Volle,Silvère Baron,J. Lobaccaro,Cheshire Sk

Published 2013 in Unknown venue

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2013
Venue
Unknown venue
Publication date
Unknown publication date
Fields of study
Biology, Medicine
Identifiers
No identifiers available.
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

The differential effects of statins on the metastatic behaviour of prostate cancer
2012cited by this paper
Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?
2012cited by this paper
Oxysterol receptors, AKT and prostate cancer.
2012cited by this paper
Impact of Circulating Cholesterol Levels on Growth and Intratumoral Androgen Concentration of Prostate Tumors
2012cited by this paper
Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.
2012cited by this paper
Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up
2012cited by this paper
Molecular link mechanisms between inflammation and cancer.
2012cited by this paper
Global cancer statistics
2011cited by this paper
Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins.
2011cited by this paper
Targeting liver X receptors in human health: deadlock or promising trail?
2011cited by this paper
Cross-talk between the Androgen Receptor and the Liver X Receptor
2011cited by this paper
Blood lipid levels and prostate cancer risk; a cohort study
2011cited by this paper
Serum total and HDL cholesterol and risk of prostate cancer
2011cited by this paper
Is statin use associated with prostate cancer aggressiveness?
2010cited by this paper
Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells
2010cited by this paper
Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer
2009cited by this paper
Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
2009cited by this paper
LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
2009cited by this paper
Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR‐623, a Novel Liver X‐Receptor Agonist, in Healthy Participants
2009cited by this paper
Abstract 1367: Tissue-specific Liver X Receptor Activation Promotes Macrophage Reverse Cholesterol Transport in vivo
2009cited by this paper
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse[S]
2009cited by this paper
Cholesterol and Cancer: Answers and New Questions
2009cited by this paper
Androgen deprivation by activating the liver X receptor.
2008cited by this paper
Interleukin 6 is associated with cachexia in patients with prostate cancer.
2007cited by this paper
Cholesterol-Lowering Drugs and Advanced Prostate Cancer Incidence in a Large U.S. Cohort
2007cited by this paper
Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility.
2007cited by this paper
Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth.
2007cited by this paper
Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study
2007cited by this paper
Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey
2007cited by this paper
The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells.
2007cited by this paper
Interleukin‐6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival
2007cited by this paper
Modulation of liver X receptor signaling as novel therapy for prostate cancer.
2007cited by this paper
Protein Kinase A Suppresses Sterol Regulatory Element-binding Protein-1C Expression via Phosphorylation of Liver X Receptor in the Liver*
2007cited by this paper
Phosphorylation of the liver X receptors
2006cited by this paper
Statin drugs and risk of advanced prostate cancer.
2006cited by this paper
Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist.
2006cited by this paper
Statins and prostate cancer risk: a case-control study.
2005cited by this paper
Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.
2005cited by this paper
Human prostate cancer risk factors
2004cited by this paper
Hepatic ABCG5 and ABCG8 Overexpression Increases Hepatobiliary Sterol Transport but Does Not Alter Aortic Atherosclerosis in Transgenic Mice*
2004cited by this paper
Crystal structure of the human liver X receptor beta ligand-binding domain in complex with a synthetic agonist.
2004cited by this paper
Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
2004cited by this paper
Cholesterol and prostate cancer
2004cited by this paper
Androgenic Suppression of ATP-binding Cassette Transporter A1 Expression in LNCaP Human Prostate Cancer Cells
2004cited by this paper
Antiproliferative Effect of Liver X Receptor Agonists on LNCaP Human Prostate Cancer Cells
2004cited by this paper
Caveolin‐1 expression is a predictor of recurrence‐free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients
2003cited by this paper
Induction of Intestinal ATP-binding Cassette Transporters by a Phytosterol-derived Liver X Receptor Agonist*
2003cited by this paper
Stimulation of Cholesterol Excretion by the Liver X Receptor Agonist Requires ATP-binding Cassette Transporters G5 and G8*
2003cited by this paper
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.
2003cited by this paper
Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models.
2003cited by this paper
Prostate cancer epidemiology.
2003cited by this paper
X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch.
2003cited by this paper
Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors α and β*
2002cited by this paper
Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells
2002cited by this paper
Uptake of a cholesterol-rich emulsion by breast cancer.
2002cited by this paper
Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.
2002cited by this paper
Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors*
2002cited by this paper
Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.
2002cited by this paper
Elevated uptake of low density lipoprotein by drug resistant human leukemic cell lines.
2002cited by this paper
Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
2001cited by this paper
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice.
2001cited by this paper
LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
2001cited by this paper
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.
2001cited by this paper
Human prostate cancer cells lack feedback regulation of low‐density lipoprotein receptor and its regulator, SREBP2
2001cited by this paper
A prospective study on intake of animal products and risk of prostate cancer
2001cited by this paper
Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low‐ and high‐grade prostatic intraepithelial neoplasia and prostatic carcinoma
2001cited by this paper
Quantitation by 1H‐NMR of dolichol, cholesterol and choline‐containing lipids in extracts of normal and phathological thyroid tissue
2000cited by this paper
Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages
2000cited by this paper
Comparative studies of prostate cancer in Japan versus the United States. A review.
2000cited by this paper
Role of LXRs in control of lipogenesis.
2000cited by this paper
Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.
2000cited by this paper
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
2000cited by this paper
Enhanced 3-hydroxy-3-methyl-glutaryl coenzyme A reductase activity in human colorectal cancer not expressing low density lipoprotein receptor.
1999cited by this paper
Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.
1999cited by this paper
Dietary fat and prostate cancer: current status.
1999cited by this paper
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies.
1999cited by this paper
Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants.
1999cited by this paper
Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα
1998cited by this paper
Elevated expression of caveolin is associated with prostate and breast cancer.
1998cited by this paper
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
1998cited by this paper
Selective expression of inducible nitric oxide synthase in human prostate carcinoma
1998cited by this paper
Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels are coordinately reduced in human renal cell carcinoma.
1996cited by this paper
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
1996cited by this paper
OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor.
1995cited by this paper
Interleukin-6: a candidate mediator of human prostate cancer morbidity.
1995cited by this paper
Cholesterol content in tumor tissues is inversely associated with high‐density lipoprotein cholesterol in serum in patients with gastrointestinal cancer
1994cited by this paper
Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia.
1994cited by this paper
The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients.
1993cited by this paper
Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors
1991cited by this paper
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County.
1991cited by this paper
Regulation of the mevalonate pathway
1990cited by this paper
Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
1985cited by this paper
Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol.
1974cited by this paper
The Cholesterol Content of Normal and Enlarged Prostates
1942cited by this paper
Tumorigenesis and Neoplastic Progression A Western-Type Diet Accelerates Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer
year unknowncited by this paper

CITED BY

No citing papers are available for this paper.